EFSPI regulatory statistics workshop 2023: analysis of registrations
Data status
Data as of 2025-01-24 at 21:41:45.
Registrations by type of institution
Registrations by background
Registrations by institution
Registrations of regulatory and HTA colleagues
Registrations by countries
Registrations by countries - map
Registrations by mode of attendance
Registrations by mode of attendance and F2F block booking status
Warning: Paket 'arsenal' wurde unter R Version 4.3.3 erstellt| Novartis (N=313) | Roche (N=97) | Total (N=410) | |
|---|---|---|---|
| mode | |||
| Face-to-face (280 Euro) | 118 (37.7%) | 51 (52.6%) | 169 (41.2%) |
| Virtual (70 Euro) | 195 (62.3%) | 46 (47.4%) | 241 (58.8%) |
Registrations by meals and wine tasting
No-shows among those who registered for face-to-face participation
| Novartis (N=118) | Roche (N=51) | Total (N=169) | |
|---|---|---|---|
| noshow | |||
| show | 78 (66.1%) | 37 (72.5%) | 115 (68.0%) |
| no show | 40 (33.9%) | 14 (27.5%) | 54 (32.0%) |